share_log

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

Moderna | 144:擬議出售證券
美股sec公告 ·  06/11 17:43
Moomoo AI 已提取核心訊息
Flagship Ventures Fund IV-Rx, L.P., an affiliate of Moderna, Inc., is set to sell 32,763 shares of Moderna's common stock, with an aggregate market value of approximately $4.86 million, on June 11, 2024. These shares were originally acquired on December 28, 2011, as part of a pre-IPO venture stage investment directly from the issuer, with cash payment. Over the past three months, Flagship Ventures has sold 200,000 shares of Moderna, generating total gross proceeds of $24.04 million.
Flagship Ventures Fund IV-Rx, L.P., an affiliate of Moderna, Inc., is set to sell 32,763 shares of Moderna's common stock, with an aggregate market value of approximately $4.86 million, on June 11, 2024. These shares were originally acquired on December 28, 2011, as part of a pre-IPO venture stage investment directly from the issuer, with cash payment. Over the past three months, Flagship Ventures has sold 200,000 shares of Moderna, generating total gross proceeds of $24.04 million.
Moderna的附屬機構Flagship Ventures Fund IV-Rx, L.P.計劃於2024年6月11日賣出32,763股Moderna普通股,總市值約爲4,860,000美元。這些股份最初是在2011年12月28日作爲風險投資的一部分直接從發行方以現金支付方式獲得的。過去三個月,Flagship Ventures已出售了200,000股Moderna股票,共獲得淨收益2,404萬美元。
Moderna的附屬機構Flagship Ventures Fund IV-Rx, L.P.計劃於2024年6月11日賣出32,763股Moderna普通股,總市值約爲4,860,000美元。這些股份最初是在2011年12月28日作爲風險投資的一部分直接從發行方以現金支付方式獲得的。過去三個月,Flagship Ventures已出售了200,000股Moderna股票,共獲得淨收益2,404萬美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息